Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Video
When Should Patients Switch from Statins to PCSK9 Inhibitors?
Author(s):
Mark Tesell, PharmD, BCPS, clinical consultant pharmacist at UMass Medical School, discusses the treatment switch from statins to PCSK9 inhibitors in patients with high cholesterol.
Mark Tesell, PharmD, BCPS, clinical consultant pharmacist at UMass Medical School, discusses the treatment switch from statins to PCSK9 inhibitors in patients with high cholesterol.
Related Videos
Related Content
